MMIRF (MedMira) EBIT per Share: $-0.00 (TTM As of Jan. 2026)


What is MedMira EBIT per Share?

MedMira MMIRF +302.48% EBIT per Share is $-0.00 as of Jan. 2026. The stock has 6 warning signs investors should review. Among 1,181 Biotechnology companies, MedMira ranks worse than 92.72% on this metric.

MedMira's EBIT per Share for the three months ended in Jan. 2026 was $0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2026 was $-0.00.

During the past 3 years, the average EBIT per Share Growth Rate was -35.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for MedMira's EBIT per Share or its related term are showing as below:

MMIRF' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -35.7   Med: 15.7   Max: 42
Current: -35.7

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of MedMira was 42.00% per year. The lowest was -35.70% per year. And the median was 15.70% per year.

MMIRF's 3-Year EBIT Growth Rate is ranked worse than
92.72% of 1181 companies
in the Biotechnology industry
Industry Median: 15.5 vs MMIRF: -35.70

MedMira's EBIT for the three months ended in Jan. 2026 was $-0.29 Mil.

MedMira  (OTCPK:MMIRF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

MedMira EBIT per Share Related Terms

MedMira EBIT per Share Historical Data

* Premium members only.

The historical data trend for MedMira's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedMira EBIT per Share Chart

MedMira Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 -0.00 -0.00 -0.00

MedMira Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.00 -0.00 -0.00 0.00

MedMira EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

MedMira's EBIT per Share for the fiscal year that ended in Jul. 2025 is calculated as

EBIT per Share(A: Jul. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-2.518/701.731
=-0.00

MedMira's EBIT per Share for the quarter that ended in Jan. 2026 is calculated as

EBIT per Share(Q: Jan. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.294/701.731
=-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $-0.00 mean?
MedMira (MMIRF) has a EBIT per Share of $-0.00 as of Jan. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on MedMira and its competitors. According to the industry distribution chart, MedMira ranks #1095 out of 1181 companies in the Biotechnology industry, placing it in the top 92.7%.
Is MedMira's EBIT per Share too high?
MedMira's current EBIT per Share is $-0.00. Based on the distribution chart, MedMira ranks #1095 out of 1181 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does MedMira's EBIT per Share compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, MedMira ranks #1095 out of 1181 companies for EBIT per Share. This places MedMira in the lower half of its industry. The industry median EBIT per Share is 15.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Biotechnology company?
The median EBIT per Share among Biotechnology companies is 15.50, based on 1,181 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on MedMira and its competitors. For the Biotechnology industry, the median EBIT per Share is 15.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedMira's current EBIT per Share is $-0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedMira stock overvalued right now?
MedMira (MMIRF) has a current EBIT per Share of $-0.00. The current EBIT per Share is $-0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For MedMira (MMIRF), the current EBIT per Share is $-0.00 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedMira Business Description

Other Exchanges MIR:Canada
Address 155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3
MedMira Inc is a biotechnology company engaged in the research, development, and manufacturing of rapid diagnostics and technologies. The company operates in one reportable operating segment, rapid diagnostic products and services. Its product line includes HIV, COVID-19, syphilis, Multiplex, Miriad RVF Toolkit, and H. pylori. The company generates revenue from North America, Europe, and other regions, with the majority generated from North America.